Uitgelicht en gespot op internet (week 16, 2022)
Hierbij een nieuwe uitgave van het supplement ‘Uitgelicht en gespot op internet‘, met een overzicht van nieuws en andere berichten die de afgelopen weken zijn gespot op het internet.
Vergeet niet om ook de ‘Events‘-pagina en de ‘Consultations‘-pagina te raadplegen.
‘Uitgelicht en gespot op internet‘ is een supplement van de ‘Nieuwsbrief voor Goede Onderzoekspraktijken‘.
Committee on Publication Ethics (COPE)
- Discovering fraud and protecting the scientific record (06-04-2022).
- COPE advice to editors on geopolitical intrusions on editorial decisions (updated 29-03-2022).
- Removing a retracted article from a third party site.
Dutch Oncology Research Platform (DORP)
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
Nationaal Comité advies dierproevenbeleid (NCad)
- Jaarverslag NCad 2021 online (20-04-2022).
- Het NCad is geëvalueerd (19-04-2022).
- Streefbeeld Cardiovasculair Onderzoek is vergevorderd (19-04-2022).
Nederlandse Federatie van Universitair Medische Centra (NFU)
Nieuwsbrief voor Goede Onderzoekspraktijken
Oorlog in Oekraine en klinisch onderzoek
US Food and Drug Administration (FDA)
- Newly added guidance documents
- Study: Black patients underrepresented in pivotal CAR T-cell trials (20-04-2022). Regulatory Focus.
- Study: Extrapolation of drug indications from study populations by FDA is ‘common’ (19-04-2022). Regulatory Focus.
- Celiac disease: FDA offers guidance on drug development (18-04-2022). Regulatory Focus.
Vereniging Innovatieve Geneesmiddelen
Overige berichten
- Weekend reads: Should ‘peer reviewers be paid?’; Kim Kardashian and conflicts of interest; scandal costs millions in grants (23-04-2022). Retraction Watch.
- Applied Clinical Trials April 2022 Issue.
- Maximizing data value for biopharma through FAIR and quality implementation: FAIR plus Q (mei 2022). Drug Discovery Today.
- A new nonprofit wants to rewrite the playbook for how the U.S. government funds science (22-04-2022). STAT.
- Sprokkelen voor matig onderzoek (22-04-2022). NRC.
- Publication of clinical trials on medicinal products: follow-up on trials authorized in Hungary (21-04-2022). Trials.
- Authors blame ‘unintentional oversight’ for including image of deceased patient in paper (19-04-2022) Retraction Watch.
- Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition (19-04-2022). Nature Medicine.
- Men and women may respond differently to vaccines. Research needs to account for that (18-04-2022). STAT.
- Scientists Question Data Behind an Experimental Alzheimer’s Drug (18-04-2022). The New York Times.
- Think Pragmatically: Investigators’ Obligations to Patient-Subjects When Research is Embedded in Care (18-04-2022). The American Journal of Bioethics.
- Singapore establishes national consortium for clinical research, innovation (13-04-2022). Healthcare IT News.
- Speech Biomarkers: A New Tool in Alzheimer’s Disease Clinical Trials (13-04-2022). Janssen.
- Putting plain language summaries into perspective (11-04-2022). Current Medical Research and Opinion.
- Automation in Scientific Writing Improving Healthcare Products Communication (april 2022). DIA Global Forum.
- The $3 Million Research Breakdown. How a star psychiatrist at the University of Illinois at Chicago violated protocols and put children at risk (26-04-2018). ProPublica.
- Child psychiatrist’s research was suspended “indefinitely” following probe (11-04-2018). Retraction Watch.